Veradigm Operating Margin 2010-2022 | MDRX
Veradigm Operating Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Operating Income | Operating Margin |
2022-12-31 | $0.59B | $-0.03B | -4.41% |
2022-09-30 | $0.60B | $0.06B | 10.10% |
2022-06-30 | $0.60B | $0.05B | 9.05% |
2022-03-31 | $0.59B | $0.08B | 12.95% |
2021-12-31 | $0.58B | $0.08B | 13.32% |
2021-09-30 | $-0.14B | $0.11B | -81.43% |
2021-06-30 | $0.08B | $0.09B | 104.94% |
2021-03-31 | $0.31B | $0.04B | 13.92% |
2020-12-31 | $0.56B | $0.01B | 1.44% |
2020-09-30 | $1.43B | $-0.17B | -12.11% |
2020-06-30 | $1.51B | $-0.16B | -10.56% |
2020-03-31 | $1.58B | $-0.13B | -8.16% |
2019-12-31 | $1.63B | $-0.10B | -6.07% |
2019-09-30 | $1.63B | $-0.09B | -5.58% |
2019-06-30 | $1.62B | $-0.09B | -5.81% |
2019-03-31 | $1.62B | $-0.16B | -9.85% |
2018-12-31 | $1.62B | $-0.17B | -10.45% |
2018-09-30 | $1.52B | $-0.11B | -7.39% |
2018-06-30 | $1.53B | $-0.09B | -5.68% |
2018-03-31 | $1.52B | $-0.01B | -0.40% |
2017-12-31 | $1.50B | $0.01B | 0.80% |
2017-09-30 | $1.55B | $0.08B | 4.97% |
2017-06-30 | $1.49B | $0.07B | 4.62% |
2017-03-31 | $1.45B | $0.07B | 4.61% |
2016-12-31 | $1.39B | $0.07B | 4.90% |
2016-09-30 | $1.47B | $0.07B | 4.83% |
2016-06-30 | $1.43B | $0.06B | 4.40% |
2016-03-31 | $1.40B | $0.05B | 3.58% |
2015-12-31 | $1.39B | $0.03B | 2.31% |
2015-09-30 | $1.38B | $0.01B | 0.72% |
2015-06-30 | $1.37B | $-0.02B | -1.31% |
2015-03-31 | $1.37B | $-0.03B | -2.41% |
2014-12-31 | $1.38B | $-0.04B | -2.83% |
2014-09-30 | $1.39B | $-0.07B | -4.90% |
2014-06-30 | $1.37B | $-0.09B | -6.71% |
2014-03-31 | $1.37B | $-0.11B | -8.13% |
2013-12-31 | $1.37B | $-0.13B | -9.25% |
2013-09-30 | $1.37B | $-0.13B | -9.18% |
2013-06-30 | $1.40B | $-0.07B | -5.27% |
2013-03-31 | $1.43B | $-0.03B | -1.96% |
2012-12-31 | $1.45B | $0.01B | 0.90% |
2012-09-30 | $1.48B | $0.09B | 5.80% |
2012-06-30 | $1.49B | $0.11B | 7.46% |
2012-03-31 | $1.47B | $0.13B | 8.48% |
2011-12-31 | $1.44B | $0.14B | 9.42% |
2011-09-30 | $1.37B | $0.10B | 7.29% |
2011-06-30 | $1.25B | $0.07B | 5.20% |
2011-03-31 | $1.08B | $0.05B | 4.98% |
2010-09-30 | $0.62B | $0.05B | 8.43% |
2010-06-30 | $0.56B | $0.09B | 15.32% |
2010-03-31 | $0.53B | $0.09B | 17.07% |
2010-02-28 | $0.51B | $0.08B | 15.76% |
2009-09-30 | $0.49B | $0.07B | 13.65% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.455B | $0.588B |
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $39.499B | 54.56 |
Hims & Hers Health (HIMS) | United States | $14.471B | 150.35 |
Tempus AI (TEM) | United States | $11.278B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.503B | 70.36 |
IRhythm Technologies (IRTC) | United States | $4.501B | 0.00 |
Privia Health (PRVA) | United States | $3.050B | 208.50 |
Enovis (ENOV) | United States | $2.060B | 11.48 |
Clover Health Investments (CLOV) | United States | $1.807B | 0.00 |
Schrodinger (SDGR) | United States | $1.722B | 0.00 |
Phreesia (PHR) | United States | $1.510B | 0.00 |
Omnicell (OMCL) | United States | $1.310B | 23.11 |
Azenta (AZTA) | United States | $1.258B | 58.45 |
10x Genomics (TXG) | United States | $1.156B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.620B | 0.00 |
Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
Talkspace (TALK) | United States | $0.499B | 149.00 |
Claritev (CTEV) | United States | $0.450B | 0.00 |
Standard BioTools (LAB) | United States | $0.410B | 0.00 |
TruBridge (TBRG) | United States | $0.376B | 834.67 |
Health Catalyst (HCAT) | United States | $0.283B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.197B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.142B | 0.00 |
Pulmonx (LUNG) | United States | $0.138B | 0.00 |
American Well (AMWL) | United States | $0.116B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
CareCloud (CCLD) | United States | $0.089B | 3.39 |
Outset Medical (OM) | United States | $0.070B | 0.00 |
111 (YI) | China | $0.068B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
HeartBeam (BEAT) | United States | $0.052B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
Zhongchao (ZCMD) | China | $0.032B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
Precipio (PRPO) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
Movano (MOVE) | United States | $0.007B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |